| The molecular analysis for therapy choice (NCI-MATCH) trial: lessons for genomic trial design KT Flaherty, R Gray, A Chen, S Li, D Patton, SR Hamilton, PM Williams, ... JNCI: Journal of the National Cancer Institute 112 (10), 1021-1029, 2020 | 163 | 2020 |
| Circulating ensembles of tumor‐associated cells: a redoubtable new systemic hallmark of cancer D Akolkar, D Patil, T Crook, S Limaye, R Page, V Datta, R Patil, C Sims, ... International Journal of cancer 146 (12), 3485-3494, 2020 | 31 | 2020 |
| Accurate screening for early-stage breast cancer by detection and profiling of circulating tumor cells T Crook, R Leonard, K Mokbel, A Thompson, M Michell, R Page, A Vaid, ... Cancers 14 (14), 3341, 2022 | 26 | 2022 |
| Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers: results from the RESILIENT trial R Nagarkar, D Patil, T Crook, V Datta, S Bhalerao, S Dhande, V Palwe, ... Oncotarget 10 (54), 5605, 2019 | 21 | 2019 |
| Evaluation of circulating tumor cell clusters for pan‐cancer noninvasive diagnostic triaging A Gaya, T Crook, N Plowman, A Ranade, S Limaye, A Bhatt, R Page, ... Cancer Cytopathology 129 (3), 226-238, 2021 | 16 | 2021 |
| Adaptive, Iterative, Long-Term Personalized Therapy Management in a Case of Stage IV Refractory NSCLC A Ranade, D Patil, A Bhatt, R Dhasare, V Datta, R Datar, D Akolkar Journal of personalized medicine 9 (3), 34, 2019 | 9 | 2019 |
| Accurate prostate cancer detection based on enrichment and characterization of prostate cancer specific circulating tumor cells S Limaye, S Chowdhury, N Rohatgi, A Ranade, N Syed, J Riedemann, ... Cancer Medicine 12 (8), 9116-9127, 2023 | 8 | 2023 |
| Profiling of circulating glial cells for accurate blood‐based diagnosis of glial malignancies K O'Neill, N Syed, T Crook, S Dubey, M Potharaju, S Limaye, A Ranade, ... International Journal of Cancer 154 (7), 1298-1308, 2024 | 4 | 2024 |
| Response to pazopanib‐based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma S Limaye, D Patil, D Akolkar, N Srivastava, R Patil, S Apurwa, S Patil, ... Clinical Case Reports 9 (11), e04986, 2021 | 3 | 2021 |
| Genomic profiling of three pathways through molecular profiling-based assignment of cancer therapy (NCI-MPACT) A Chen, S Kummar, SS Khan, N Moore, L Rubinstein, GOS Coyne, ... Annals of Oncology 30, v164-v165, 2019 | 3 | 2019 |
| Class I histiocytosis: response to combination of etoposide and prednisolone. V Datta, OP Mishra, BK Das, M Kumar, V Bhargava, PN Singla Indian Pediatr, 1999 | 3 | 1999 |
| Multi-analyte liquid biopsies for molecular pathway guided personalized treatment selection in advanced refractory cancers: A clinical utility pilot study D Patil, D Akolkar, R Nagarkar, N Srivastava, V Datta, S Patil, S Apurwa, ... Frontiers in Oncology 12, 972322, 2022 | 2 | 2022 |
| Real-time non-invasive chemoresistance profiling of circulating tumor associated cells in breast cancers to determine resistance towards mitotic inhibitors A Srinivasan, D Akolkar, D Patil, S Limaye, R Page, A Ranade, R Patil, ... European Journal of Cancer 138, S76-S77, 2020 | 2 | 2020 |
| Multi-analyte liquid biopsies based treatment in advanced refractory cancers. S Limaye, D Patil, DB Akolkar, T Crook, A Ranade, A Bhatt, V Datta, ... Journal of Clinical Oncology 38 (15_suppl), e15623-e15623, 2020 | 2 | 2020 |
| Effect of previous chemotherapy treatments on circulating tumor-associated cells in colorectal cancer. S Limaye, T Crook, R Page, D Patil, D Akolkar, V Datta, S Schuster, ... Journal of Clinical Oncology 38 (4_suppl), 194-194, 2020 | 2 | 2020 |
| Coupled Electromagnetics-Multiphase Porous Media Model for Microwave Combination Heating VRAK Datta | 2 | 2008 |
| Profiling of circulating glial cells allows accurate blood-based diagnosis of glial malignancies K O’Neill, N Syed, T Crook, S Dubey, M Potharaju, S Limaye, A Ranade, ... | 1 | 2022 |
| Circulating tumor cell assay to non-invasively evaluate PD-L1 and other therapeutic targets in multiple cancers R Page, D Patil, D Akolkar, SS Murthy, K Bendale, R Patil, P Fulmali, ... Plos one 17 (6), e0270139, 2022 | 1 | 2022 |
| Angiogenesis inhibitors in personalized combination regimens for the treatment of advanced refractory cancers T Crook, D Patil, R Nagarkar, A Gaya, N Plowman, S Limaye, ... Frontiers in Molecular Medicine 1, 749283, 2021 | 1 | 2021 |
| A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer S Limaye, P Kumar, R Pragya, J Sambath, D Patil, A Srinivasan, S Apurva, ... Oncotarget 11 (46), 4358, 2020 | 1 | 2020 |
